TrialJournal of infection and public health2022

The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial).

M Al Ghobain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.